This clinical trial focuses on studying acute appendicitis, which is a condition where the appendix becomes inflamed and painful. The study includes both uncomplicated and complicated forms of this condition. The purpose of the study is to understand the causes of acute appendicitis and to examine how different treatments affect the bacteria in the gut, known as the microbiota. The study will also look at how the length of hospital stay might influence the bacteria in the gut.
Participants in the study will receive one of several antimicrobial treatments. These treatments include levofloxacin, which is taken as a tablet, ertapenem, which is given as a solution for infusion, metronidazole, which is also taken as a tablet, and moxifloxacin, which is provided as a film-coated tablet. These medications are used to help fight infections and are part of the study to see how they impact the gut microbiota.
The study will follow participants over a period of time to observe changes in the gut microbiota and to determine if there is any connection between these changes and the severity of appendicitis. Participants will be monitored for the duration of their treatment, which varies depending on the medication, and the effects on their gut bacteria will be evaluated. The study aims to provide insights into the relationship between antimicrobial treatments and gut health in patients with acute appendicitis.



Finland